5Y Capital

5Y Capital is a private equity and venture capital firm based in Shanghai, China, focused on seed, start-up, early venture, and growth capital investments. Founded in 2008 and previously known as Morningside Venture Capital, the firm manages approximately USD 5 billion in dual-currency funds, supported by global investors such as sovereign wealth funds, family offices, and endowments. 5Y Capital primarily invests in various sectors, including healthcare, technology, fintech, media, software, life sciences, and education, with a special emphasis on medical treatment, biotechnology, and digital health. The firm seeks opportunities in China and other emerging markets across Asia and the Pacific, aiming to support entrepreneurs in building innovative companies. 5Y Capital typically makes initial investments exceeding USD 500,000 per portfolio company and operates as a subsidiary of Morningside Group, which has been active in venture capital investments since 1992.

Ka Chang

Managing Director

Zhe Chen

Managing Director

Peter Chen

Managing Director

Yu Cheng

Partner

Lu Huang

Director

Victor Jin

Managing Director

Jiangyun Jin

Managing Director

Ted Xutian Jing

Managing Director

Levi Liu

Partner

Qin Liu

Co-Founder, Investment Director and Board Member

Richard Liu

Founding Partner

Stephanie O'Brien

Investment Professional

Ken Shi

Founding Partner

Yi Sun

Senior Associate

Jerry Tong

Senior Associate

Yunhong Wei

Investor

Yaopeng Xing

Investor

Patricia Zhuoya Yang

Investor

Tony Yeung

Managing Director

Cloris You Youdan

Managing Director

Elwin Yuan

Partner

Yuan Ye

Partner

Fisher Zhang

Partner

Fei Zhang

Partner

Bo Zhang

Managing Director

Past deals in Artificial Intelligence

XYZ Robotics

Series B in 2022
XYZ Robotics Inc. specializes in automating logistics and manufacturing processes through advanced AI-enabled robotic perception and manipulation technology. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, China, the company focuses on developing autonomous robotic solutions for tasks such as sorting and picking. Their robotics systems can efficiently organize random warehouse goods into customer order groups, enhancing supply chain management. By leveraging deep learning and sophisticated robotic manipulation algorithms, XYZ Robotics streamlines operations between batch picking and final packaging, ultimately expediting the order fulfillment process.

Hai Robotics

Series D in 2022
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

Metis Pharmaceuticals

Series B in 2022
Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. The company's software helps pharmaceutical companies accelerate the movement of new drugs in the pipeline through optimizing pre-clinical trial operations, enabling users to efficiently conduct research and design.

METiS Therapeutics

Series B in 2022
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

SpeedFox

Series A in 2022
Developer of smart cleaning appliances. The company develops a smart cleaning appliance that integrates vacuuming, sweeping, mopping functions into one device, enabling users to clean hard floors such as wood floor and tile floor efficiently in home scenarios.

Regenerative Bio

Angel Round in 2022
Regenerative Bio is a pioneering biotechnology company focused on anti-aging solutions through the integration of artificial intelligence and advanced computing technologies. The company is dedicated to researching and developing ingredients, formulations, and therapies aimed at mitigating the effects of aging and enhancing overall health. By leveraging AI, quantum physics, and high-throughput preparation methods, Regenerative Bio seeks to improve cellular health and energy metabolism, ultimately promoting longer, healthier lives. Their innovative approach combines pharmaceutical technology with biological research, addressing age-related health issues and contributing to the field of longevity science.

Parametrix.ai

Series B in 2022
Developer of AI technology to revolutionize game development. The company utilizes AI technology to aid in complex environmental sensing within games, game playing/decision making, creating modeling teams and enemies, and developing player survival/evolution scenarios.

Xbiome

Series B in 2021
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Vastai Technologies

Series B in 2021
Vastai Technologies specializes in the development of semiconductor chips tailored for computer vision, video processing, and various artificial intelligence applications. The company's innovative products are engineered to enhance the computing capabilities of AI visual applications, allowing manufacturers of computer devices to integrate advanced chip technology into their offerings. By focusing on optimizing performance in these specific areas, Vastai Technologies aims to support the growing demand for efficient and powerful AI solutions in the market.

Metis Pharmaceuticals

Series A in 2021
Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. The company's software helps pharmaceutical companies accelerate the movement of new drugs in the pipeline through optimizing pre-clinical trial operations, enabling users to efficiently conduct research and design.

METiS Therapeutics

Series A in 2021
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

DeepCure

Series A in 2021
DeepCure Inc. offers drugs discovery services using artificial intelligence technology. Its products include De-novo Lead Discovery, Artificial Intelligence-driven Lead Optimization, and MoIDB. De-novo Lead Discovery uses artificial intelligence algorithms to analyze drug candidates from virtual library. Artificial Intelligence-driven Lead Optimization identifies optimization steps to improve the development of drugs. MolDB is designed to maximize scale, diversity, and synthesizability of chemical search space. DeepCure Inc. develops new drug through molecular feature extraction, MoIDB, artificial intelligence predictive modeling and feedback loop. The company was founded in 2018 and is based in Boston, Massachusetts.

Huckleberry Labs

Series A in 2021
Huckleberry Labs is focused on enhancing children's sleep by making behavioral expertise accessible and affordable for families. The company has developed an evidence-based program that combines artificial intelligence with human expertise. Their mobile application tracks a child's sleep patterns over a week, providing insights into their sleep conditions. Based on this data, the app offers a straightforward program for parents to help improve their children's sleep habits. Through this innovative approach, Huckleberry Labs aims to support families in addressing sleep challenges effectively.

PhiGent Robotics

Seed Round in 2021
PhiGent Robotics offers autonomous driving solutions.

Hai Robotics

Series C in 2021
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

Hai Robotics

Series D in 2021
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

XtalPi

Series D in 2021
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

XYZ Robotics

Series B in 2021
XYZ Robotics Inc. specializes in automating logistics and manufacturing processes through advanced AI-enabled robotic perception and manipulation technology. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, China, the company focuses on developing autonomous robotic solutions for tasks such as sorting and picking. Their robotics systems can efficiently organize random warehouse goods into customer order groups, enhancing supply chain management. By leveraging deep learning and sophisticated robotic manipulation algorithms, XYZ Robotics streamlines operations between batch picking and final packaging, ultimately expediting the order fulfillment process.

Xiaoice

Series A in 2021
Xiaoice is an AI company that develops a chatbot that acts as a digital assistant with the capability to understand human conversations. Xiaoice allows cross-platform interactions, enabling users to enjoy the convenience of artificial intelligence. Xiaoice is designed as a teenage girl and is touted as an empathic computing framework focusing on longer back-and-forth conversations with humans instead of simply answering questions or obeying commands like most bots. Its technology covers natural language processing, computer voice, computer vision, and AI content generation.

neoX BIOTECH

Venture Round in 2021
neoX BIOTECH is a biotechnology company that develops antigen-based cancer vaccine through a deep understanding of biophysics and the use of artificial intelligence. It develops a neoantigen prediction and TCR screening platform. The company was founded in 2018 and is based in Beijing, China.

AgileX

Venture Round in 2021
AgileX Robotics (Dongguan) CO., Ltd designs and manufactures mobile robot products. It offers Unmanned ground vehicle (UGV), automated guided vehicle (AGV), and steering-by-wire modified electric vehicles. It serves logistics transportation, security patrolling, and agricultural and animal husbandry industries. The company was founded in 2017 and is based in Dongguan, China with an additional office in Shenzhen, China.

ONES

Series B in 2021
ONES.AI is a technology company specializing in enterprise-level research and development management solutions. Founded in 2015, the company offers a suite of tools designed to enhance project and program management. Its offerings include ONES Project for overseeing project progress, ONES Plan for managing programs, ONES Wiki for repository management, ONES TestCase for managing test cases and plans, and ONES Pipeline for continuous integration and delivery management. ONES.AI has served over 20,000 enterprises and organizations across various sectors, including new retail, gaming, live broadcasting, fintech, and artificial intelligence. The company's platform aims to improve management effectiveness and operational efficiency for its clients.

Hai Robotics

Series B in 2021
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

Pony.ai

Series C in 2021
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.

neoX BIOTECH

Series A in 2021
neoX BIOTECH is a biotechnology company that develops antigen-based cancer vaccine through a deep understanding of biophysics and the use of artificial intelligence. It develops a neoantigen prediction and TCR screening platform. The company was founded in 2018 and is based in Beijing, China.

Parametrix.ai

Series A in 2021
Developer of AI technology to revolutionize game development. The company utilizes AI technology to aid in complex environmental sensing within games, game playing/decision making, creating modeling teams and enemies, and developing player survival/evolution scenarios.

Galixir

Series A in 2020
Galixir is an artificial intelligence technology to promote the research and development of new drugs. Our artificial intelligence drug discovery platform can help drug research and development scientists greatly save time and cost in drug development. At the same time, our platform also provides comprehensive patent protection coverage for the drugs developed. Relying on cutting-edge artificial intelligence technology, Xingyao combines engineering chemistry, computational chemistry, computational biology, and cloud computing technologies to serve the various processes of drug development.

AliveX

Angel Round in 2020
AliveX is a developer of an AI-driven immunology platform that focuses on biomarker discovery for early cancer screening, precision medicine, and treatment monitoring. By integrating multi-omics data, artificial intelligence, and computational biology, the platform aims to decode the human immune system. This innovative approach enables collaboration with leading clinicians, research institutions, and pharmaceutical companies to address significant clinical challenges. AliveX's efforts are directed towards transforming life sciences research and advancing the next generation of precision diagnostics and treatments in the field of immunology.

Shukun

Series C in 2020
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

Horizon Robotics

Series C in 2020
Horizon Robotics, founded in 2015 and headquartered in Beijing, China, specializes in developing advanced chips for robotics and artificial intelligence applications. The company focuses on providing integrated, open embedded AI solutions that are designed to be high-performance, low-power, and cost-effective. Horizon Robotics aims to enable a wide range of devices, including autonomous vehicles, to operate with enhanced intelligence, facilitating capabilities such as perception, understanding, and decision-making to improve safety and convenience. The company's co-founding team possesses expertise in algorithms, software, hardware, and chip development, supported by a robust research and development team with significant industry experience. Horizon Robotics has garnered considerable investment from prominent venture capital firms and notable investors, positioning itself as a leading player in the global AI startup landscape.

xKool

Venture Round in 2020
xKool Technology specializes in the application of artificial intelligence to urban planning and architectural design. The company aims to enhance decision-making processes in these fields by providing innovative solutions that leverage deep learning, machine learning, and big data analytics. Its primary offerings include an artificial intelligence design cloud platform and accompanying cloud services, which facilitate faster and more precise design and planning for design institutes, real estate developers, and planning departments. By enabling scientific project comparisons through data analysis and fostering productive collaboration among project partners, xKool contributes to the intelligent upgrade of the building industry.

Curai

Series B in 2020
Curai is a virtual care company that leverages artificial intelligence to provide chat-based primary care services at reduced costs. Founded in 2017 by Neal Khosla and Xavier Amatriain, the company is headquartered in Palo Alto and aims to make high-quality, affordable primary care accessible globally. Curai's platform combines the expertise of clinicians with advanced AI technologies, facilitating a learning healthcare system that enhances the efficiency and effectiveness of care delivery. By helping patients communicate relevant information to medical professionals, Curai enables more accurate diagnoses and fosters improved patient outcomes. The service is available to individuals directly or through partnerships with enterprises.

Vastai Technologies

Series A in 2020
Vastai Technologies specializes in the development of semiconductor chips tailored for computer vision, video processing, and various artificial intelligence applications. The company's innovative products are engineered to enhance the computing capabilities of AI visual applications, allowing manufacturers of computer devices to integrate advanced chip technology into their offerings. By focusing on optimizing performance in these specific areas, Vastai Technologies aims to support the growing demand for efficient and powerful AI solutions in the market.

Xbiome

Series B in 2020
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Zilliz

Series B in 2020
Zilliz is a technology company founded in 2017 and headquartered in San Francisco, California, with additional offices in China. It specializes in developing an intelligent data processing platform that enhances query performance, utilizing GPU hardware acceleration. Zilliz is renowned for its open-source project Milvus, which focuses on AI-powered unstructured data analysis and vector similarity search. Since its release in 2019, Milvus has gained significant traction, attracting over 400 enterprise users and engaging more than 120 contributors on GitHub. Its applications are diverse, encompassing areas such as image processing, computer vision, natural language processing, speech recognition, recommendation engines, and drug development. In 2020, Milvus became an incubation-stage project at the LF AI & Data Foundation, reflecting its active development and community support.

Pony.ai

Venture Round in 2020
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.

XtalPi

Series C in 2020
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

XYZ Robotics

Series A in 2020
XYZ Robotics Inc. specializes in automating logistics and manufacturing processes through advanced AI-enabled robotic perception and manipulation technology. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, China, the company focuses on developing autonomous robotic solutions for tasks such as sorting and picking. Their robotics systems can efficiently organize random warehouse goods into customer order groups, enhancing supply chain management. By leveraging deep learning and sophisticated robotic manipulation algorithms, XYZ Robotics streamlines operations between batch picking and final packaging, ultimately expediting the order fulfillment process.

Galixir

Seed Round in 2020
Galixir is an artificial intelligence technology to promote the research and development of new drugs. Our artificial intelligence drug discovery platform can help drug research and development scientists greatly save time and cost in drug development. At the same time, our platform also provides comprehensive patent protection coverage for the drugs developed. Relying on cutting-edge artificial intelligence technology, Xingyao combines engineering chemistry, computational chemistry, computational biology, and cloud computing technologies to serve the various processes of drug development.

neoX BIOTECH

Venture Round in 2020
neoX BIOTECH is a biotechnology company that develops antigen-based cancer vaccine through a deep understanding of biophysics and the use of artificial intelligence. It develops a neoantigen prediction and TCR screening platform. The company was founded in 2018 and is based in Beijing, China.

Shenshang Keji

Angel Round in 2019
Shenshang Technology designs and develops artificial intelligence software that provides fashion design solutions. The company was founded in 2019 and is based in Beijing, China.

ONES

Series B in 2019
ONES.AI is a technology company specializing in enterprise-level research and development management solutions. Founded in 2015, the company offers a suite of tools designed to enhance project and program management. Its offerings include ONES Project for overseeing project progress, ONES Plan for managing programs, ONES Wiki for repository management, ONES TestCase for managing test cases and plans, and ONES Pipeline for continuous integration and delivery management. ONES.AI has served over 20,000 enterprises and organizations across various sectors, including new retail, gaming, live broadcasting, fintech, and artificial intelligence. The company's platform aims to improve management effectiveness and operational efficiency for its clients.

Xbiome

Series B in 2019
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Cognoa

Series A in 2019
Cognoa, Inc. is a pediatric behavioral health company based in Palo Alto, California, focused on developing digital diagnostic and therapeutic solutions for children at risk of developmental delays, including autism. The company's online application allows parents and caregivers to assess and monitor their child's cognitive development through a series of behavioral questions and a brief video recording of the child at play. This process generates scores and personalized recommendations, helping families understand their child's risk for developmental disorders and facilitating communication with healthcare providers. By utilizing responsible artificial intelligence, Cognoa aims to identify subtle signs of developmental delays and support informed clinical diagnoses. Its products are designed to be routinely prescribed by pediatricians and are intended to improve the standard of care for diagnosing and treating behavioral health conditions in children.

Aural Analytics

Seed Round in 2019
Aural Analytics, Inc. is a Scottsdale, Arizona-based company founded in 2015 that focuses on developing applications for monitoring brain health. The company has created a multi-modal brain health analytics platform that utilizes advances in artificial intelligence, neuroscience, and speech analytics to detect changes in neurological health. By leveraging proprietary metrics, Aural Analytics transforms smartphones and tablets into effective brain health monitors, capturing subtle, clinically relevant aspects of a patient's condition through speech samples. This technology enhances traditional functional rating scales used in clinical trials by providing objective, continuous outcomes, thereby allowing for more reliable evaluations of drug efficacy and other interventions. Aural Analytics' platform aims to reveal incremental changes in neurological health, facilitating accurate assessments by medical professionals.

XYZ Robotics

Series A in 2019
XYZ Robotics Inc. specializes in automating logistics and manufacturing processes through advanced AI-enabled robotic perception and manipulation technology. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, China, the company focuses on developing autonomous robotic solutions for tasks such as sorting and picking. Their robotics systems can efficiently organize random warehouse goods into customer order groups, enhancing supply chain management. By leveraging deep learning and sophisticated robotic manipulation algorithms, XYZ Robotics streamlines operations between batch picking and final packaging, ultimately expediting the order fulfillment process.

XtalPi

Series B in 2019
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

Xmov

Series A in 2019
Xmov is an AI company focusing on computer vision and computer graphics.

Xbiome

Series A in 2019
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Zhuiyi

Series C in 2019
Zhuiyi Technology is an artificial intelligence company based in Shenzhen, China, specializing in deep learning and natural language processing. The firm develops AI solutions, including a chatbot named YiBot, designed to facilitate interactions between humans and enterprises. Its offerings encompass AI services for semantics, speech, and vision, enabling businesses to enhance customer service, conduct big data analysis, and deliver personalized services. Zhuiyi Technology's AI digital employee intelligence platform can be tailored for various business scenarios, supporting corporate and government functions in marketing, operations, and office tasks. The company serves a diverse range of industries, including finance, Internet, tourism, retail, real estate, and education, positioning itself as a key player in the field of enterprise intelligent services.

Horizon Robotics

Series B in 2019
Horizon Robotics, founded in 2015 and headquartered in Beijing, China, specializes in developing advanced chips for robotics and artificial intelligence applications. The company focuses on providing integrated, open embedded AI solutions that are designed to be high-performance, low-power, and cost-effective. Horizon Robotics aims to enable a wide range of devices, including autonomous vehicles, to operate with enhanced intelligence, facilitating capabilities such as perception, understanding, and decision-making to improve safety and convenience. The company's co-founding team possesses expertise in algorithms, software, hardware, and chip development, supported by a robust research and development team with significant industry experience. Horizon Robotics has garnered considerable investment from prominent venture capital firms and notable investors, positioning itself as a leading player in the global AI startup landscape.

Shukun

Series B in 2019
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

Jitjatjo

Series A in 2019
Creating opportunities through technology is what we do; it’s not who we are. We exist because we want to help people reach their potential, our talent to feel valued, and our business partners to thrive. We believe everyone, especially now, needs a champion, needs to be seen, needs to feel heard, and needs to be believed in. It’s time to embrace change, transform the way we work, and intentionally create a future with opportunity in abundance. In 2015, we set out to design and develop a platform that would transform the way people worked, maximize productivity, empower lifestyle choices, and encourage human betterment. We knew it would be essential to consistently demonstrate our integrity to build trust. Choosing to lead by example, we first launched our labor marketplace to help people reach their potential and enable businesses to access talent on demand. In turn, the marketplace fuels our Empathic Intelligence, ultimately driving labor model transformation.

Soul APP

Series C in 2018
SOUL is a social network that uses AI to help users find their soul mates.

Xmov

Seed Round in 2018
Xmov is an AI company focusing on computer vision and computer graphics.

ONES

Series A in 2018
ONES.AI is a technology company specializing in enterprise-level research and development management solutions. Founded in 2015, the company offers a suite of tools designed to enhance project and program management. Its offerings include ONES Project for overseeing project progress, ONES Plan for managing programs, ONES Wiki for repository management, ONES TestCase for managing test cases and plans, and ONES Pipeline for continuous integration and delivery management. ONES.AI has served over 20,000 enterprises and organizations across various sectors, including new retail, gaming, live broadcasting, fintech, and artificial intelligence. The company's platform aims to improve management effectiveness and operational efficiency for its clients.

Shukun

Series A in 2018
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

SenseTime

Series C in 2018
SenseTime is an artificial intelligence company based in Beijing, China, founded in 2014. It specializes in computer vision and deep learning technologies, offering a range of solutions including face and body analysis, image recognition, and video comprehension. The company develops advanced applications for various sectors, such as smart cities, intelligent automobiles, healthcare, finance, and education. Notably, SenseTime's face recognition technology is widely adopted, serving over 300 companies, including major players like China Mobile and Huawei, with an impressive accuracy rate of one error in 100,000. Additionally, SenseTime is engaged in research and development of AI technologies and provides AI software and hardware products across different industries. Its operations extend beyond China to offices in Japan and Singapore, reflecting its commitment to harnessing AI for diverse applications globally.

EOITEK

Series A in 2018
EOITEK develops and delivers big data analysis solutions. It offers AIOps, a self-developed intelligent operation and maintenance product that collects, processes, analyzes, and displays multi-dimensional full-scale operation and maintenance data, including fault events, performance indicators, various logs, operation and maintenance work orders, and configuration data. The company’s solutions are deployed onsite and are available as a subscription service model. It serves customer in various industries, including banking, insurance, securities, manufacturing, energy, and transportation. The company was founded in 2014 and is based in Shanghai, China.

Zilliz

Series A in 2018
Zilliz is a technology company founded in 2017 and headquartered in San Francisco, California, with additional offices in China. It specializes in developing an intelligent data processing platform that enhances query performance, utilizing GPU hardware acceleration. Zilliz is renowned for its open-source project Milvus, which focuses on AI-powered unstructured data analysis and vector similarity search. Since its release in 2019, Milvus has gained significant traction, attracting over 400 enterprise users and engaging more than 120 contributors on GitHub. Its applications are diverse, encompassing areas such as image processing, computer vision, natural language processing, speech recognition, recommendation engines, and drug development. In 2020, Milvus became an incubation-stage project at the LF AI & Data Foundation, reflecting its active development and community support.

Pony.ai

Series A in 2018
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.

Soul APP

Series B in 2018
SOUL is a social network that uses AI to help users find their soul mates.

Soul APP

Series B in 2018
SOUL is a social network that uses AI to help users find their soul mates.

Zhuiyi

Series B in 2017
Zhuiyi Technology is an artificial intelligence company based in Shenzhen, China, specializing in deep learning and natural language processing. The firm develops AI solutions, including a chatbot named YiBot, designed to facilitate interactions between humans and enterprises. Its offerings encompass AI services for semantics, speech, and vision, enabling businesses to enhance customer service, conduct big data analysis, and deliver personalized services. Zhuiyi Technology's AI digital employee intelligence platform can be tailored for various business scenarios, supporting corporate and government functions in marketing, operations, and office tasks. The company serves a diverse range of industries, including finance, Internet, tourism, retail, real estate, and education, positioning itself as a key player in the field of enterprise intelligent services.

Horizon Robotics

Series A in 2017
Horizon Robotics, founded in 2015 and headquartered in Beijing, China, specializes in developing advanced chips for robotics and artificial intelligence applications. The company focuses on providing integrated, open embedded AI solutions that are designed to be high-performance, low-power, and cost-effective. Horizon Robotics aims to enable a wide range of devices, including autonomous vehicles, to operate with enhanced intelligence, facilitating capabilities such as perception, understanding, and decision-making to improve safety and convenience. The company's co-founding team possesses expertise in algorithms, software, hardware, and chip development, supported by a robust research and development team with significant industry experience. Horizon Robotics has garnered considerable investment from prominent venture capital firms and notable investors, positioning itself as a leading player in the global AI startup landscape.

Jitjatjo

Seed Round in 2017
Creating opportunities through technology is what we do; it’s not who we are. We exist because we want to help people reach their potential, our talent to feel valued, and our business partners to thrive. We believe everyone, especially now, needs a champion, needs to be seen, needs to feel heard, and needs to be believed in. It’s time to embrace change, transform the way we work, and intentionally create a future with opportunity in abundance. In 2015, we set out to design and develop a platform that would transform the way people worked, maximize productivity, empower lifestyle choices, and encourage human betterment. We knew it would be essential to consistently demonstrate our integrity to build trust. Choosing to lead by example, we first launched our labor marketplace to help people reach their potential and enable businesses to access talent on demand. In turn, the marketplace fuels our Empathic Intelligence, ultimately driving labor model transformation.

SenseTime

Series B in 2017
SenseTime is an artificial intelligence company based in Beijing, China, founded in 2014. It specializes in computer vision and deep learning technologies, offering a range of solutions including face and body analysis, image recognition, and video comprehension. The company develops advanced applications for various sectors, such as smart cities, intelligent automobiles, healthcare, finance, and education. Notably, SenseTime's face recognition technology is widely adopted, serving over 300 companies, including major players like China Mobile and Huawei, with an impressive accuracy rate of one error in 100,000. Additionally, SenseTime is engaged in research and development of AI technologies and provides AI software and hardware products across different industries. Its operations extend beyond China to offices in Japan and Singapore, reflecting its commitment to harnessing AI for diverse applications globally.

Xiaoxun Intelligent

Venture Round in 2017
Xiaoxun Intelligent is a high-tech enterprise focusing on children's smart wear. It is developing trackers and wearables for children, accompanying them with high-quality, secure, and intelligent products throughout their childhood.

BIGO

Series C in 2017
BIGO Technology Pte. Ltd. is a rapidly expanding mobile Internet company based in Singapore, founded in 2014. It specializes in video broadcasting and VoIP-related products, leveraging advanced Artificial Intelligence technology to enhance user experience. The company offers a diverse range of applications, including Bigo Live for live streaming, Likee for short-form videos, and imo for messaging and voice calls. With a presence in over 150 countries and more than 400 million monthly active users, BIGO aims to foster connections among individuals by providing innovative platforms for self-expression and social interaction. The company operates more than 30 offices and six R&D centers globally, reinforcing its commitment to technology-driven growth and user engagement.

BIGO

Series C in 2017
BIGO Technology Pte. Ltd. is a rapidly expanding mobile Internet company based in Singapore, founded in 2014. It specializes in video broadcasting and VoIP-related products, leveraging advanced Artificial Intelligence technology to enhance user experience. The company offers a diverse range of applications, including Bigo Live for live streaming, Likee for short-form videos, and imo for messaging and voice calls. With a presence in over 150 countries and more than 400 million monthly active users, BIGO aims to foster connections among individuals by providing innovative platforms for self-expression and social interaction. The company operates more than 30 offices and six R&D centers globally, reinforcing its commitment to technology-driven growth and user engagement.

Soul APP

Series A in 2017
SOUL is a social network that uses AI to help users find their soul mates.

Cognoa

Series A in 2016
Cognoa, Inc. is a pediatric behavioral health company based in Palo Alto, California, focused on developing digital diagnostic and therapeutic solutions for children at risk of developmental delays, including autism. The company's online application allows parents and caregivers to assess and monitor their child's cognitive development through a series of behavioral questions and a brief video recording of the child at play. This process generates scores and personalized recommendations, helping families understand their child's risk for developmental disorders and facilitating communication with healthcare providers. By utilizing responsible artificial intelligence, Cognoa aims to identify subtle signs of developmental delays and support informed clinical diagnoses. Its products are designed to be routinely prescribed by pediatricians and are intended to improve the standard of care for diagnosing and treating behavioral health conditions in children.

Zhuiyi

Series A in 2016
Zhuiyi Technology is an artificial intelligence company based in Shenzhen, China, specializing in deep learning and natural language processing. The firm develops AI solutions, including a chatbot named YiBot, designed to facilitate interactions between humans and enterprises. Its offerings encompass AI services for semantics, speech, and vision, enabling businesses to enhance customer service, conduct big data analysis, and deliver personalized services. Zhuiyi Technology's AI digital employee intelligence platform can be tailored for various business scenarios, supporting corporate and government functions in marketing, operations, and office tasks. The company serves a diverse range of industries, including finance, Internet, tourism, retail, real estate, and education, positioning itself as a key player in the field of enterprise intelligent services.

Horizon Robotics

Seed Round in 2015
Horizon Robotics, founded in 2015 and headquartered in Beijing, China, specializes in developing advanced chips for robotics and artificial intelligence applications. The company focuses on providing integrated, open embedded AI solutions that are designed to be high-performance, low-power, and cost-effective. Horizon Robotics aims to enable a wide range of devices, including autonomous vehicles, to operate with enhanced intelligence, facilitating capabilities such as perception, understanding, and decision-making to improve safety and convenience. The company's co-founding team possesses expertise in algorithms, software, hardware, and chip development, supported by a robust research and development team with significant industry experience. Horizon Robotics has garnered considerable investment from prominent venture capital firms and notable investors, positioning itself as a leading player in the global AI startup landscape.

Mioji

Series B in 2015
Mioji uses big data and artificial intelligence to provide travel itinerary with only one click. Mioji collects millions of travel related websites in dozens of languages and build a structured database with billions of information node through semantic understanding. Mioji now provides products in flights, hotels, car rentals, and tickets for concerts and sports games.

BIGO

Series B in 2015
BIGO Technology Pte. Ltd. is a rapidly expanding mobile Internet company based in Singapore, founded in 2014. It specializes in video broadcasting and VoIP-related products, leveraging advanced Artificial Intelligence technology to enhance user experience. The company offers a diverse range of applications, including Bigo Live for live streaming, Likee for short-form videos, and imo for messaging and voice calls. With a presence in over 150 countries and more than 400 million monthly active users, BIGO aims to foster connections among individuals by providing innovative platforms for self-expression and social interaction. The company operates more than 30 offices and six R&D centers globally, reinforcing its commitment to technology-driven growth and user engagement.

Deep Spring Healthcare

Angel Round in 2015
Developer of a medical assistant application software based on artificial intelligence technology. The company's application software provides users with private doctor services, and has now opened consulting services for obstetrics and gynecology and pediatrics, enabling users to have medical services remotely.

Mioji

Series A in 2014
Mioji uses big data and artificial intelligence to provide travel itinerary with only one click. Mioji collects millions of travel related websites in dozens of languages and build a structured database with billions of information node through semantic understanding. Mioji now provides products in flights, hotels, car rentals, and tickets for concerts and sports games.

Cognoa

Series A in 2013
Cognoa, Inc. is a pediatric behavioral health company based in Palo Alto, California, focused on developing digital diagnostic and therapeutic solutions for children at risk of developmental delays, including autism. The company's online application allows parents and caregivers to assess and monitor their child's cognitive development through a series of behavioral questions and a brief video recording of the child at play. This process generates scores and personalized recommendations, helping families understand their child's risk for developmental disorders and facilitating communication with healthcare providers. By utilizing responsible artificial intelligence, Cognoa aims to identify subtle signs of developmental delays and support informed clinical diagnoses. Its products are designed to be routinely prescribed by pediatricians and are intended to improve the standard of care for diagnosing and treating behavioral health conditions in children.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.